🏘️ Community Building at WeHealth 🏘️ At WeHealth, we understand the power of community in supporting health and well-being. By fostering online communities for specific conditions, we provide invaluable peer support and a sense of belonging. Our platform strengthens patient connections and builds supportive health communities where everyone feels seen and heard. 🤝 Foster meaningful peer support. 💬 Create a sense of belonging. 🌟 Build strong, supportive health communities. Join us in creating spaces where patients can connect, share, and thrive together. #CommunityBuilding #PeerSupport #WeHealth #PatientEngagement #HealthcareCommunity
WeHealth
Biotechnology Research
Los Angeles, CA 84 followers
Putting patients at the forefront of health outreach, advancing scientific advancement & promoting equitable healthcare✨
About us
WeHealth is a leading patient engagement platform that uses innovative, patient-driven outreach campaigns to connect individuals with health initiatives, resources, treatments, and clinical trials. Our mission is to place patients at the forefront of health outreach, accelerating scientific advancement and promoting equitable healthcare for all communities. Our versatile platform supports patient engagement for a wide range of healthcare objectives by empowering patients to lead health outreach, ensuring higher engagement and retention rates for your programs. Our Approach: 1. Patient-Centric Approach: Empowering patients to take charge of their health outreach. 2. Comprehensive Solutions: Supporting diverse healthcare needs, from clinical trials to broader health initiatives. 3. Innovative Technology: Offering unmatched visibility and efficiency in patient recruitment. 4. Equitable Healthcare: Promoting equity and accessibility in all our campaigns. Our approach transforms how biotech, healthcare professionals, clinical researchers, and physicians connect with patients. We specialize in crafting tailored, patient-centric campaigns that not only boost patient recruitment but also build stronger, more informed communities. Contact us today to learn more about our services and how we can support your patient engagement efforts.
- Website
-
https://www.wehealth.io/sponsor
External link for WeHealth
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Los Angeles, CA
- Type
- Privately Held
- Founded
- 2017
- Specialties
- health technology, health equity initiatives, clinical research , patient advocacy, patient driven research, patient management, care coordinators, patient care, and patient concierge services
Locations
-
Primary
4331 Berenice Ave
Los Angeles, CA 90031, US
Employees at WeHealth
Updates
-
Ever wonder how pharmacists are transforming cancer care behind the scenes? 💡 This is your chance to find out! Join the FDA Oncology Center of Excellence on Oct. 10 for "The Faces of FDA Pharmacy" virtual webinar. Hear from FDA pharmacists about their crucial roles in developing cutting-edge oncology treatments for cancer patients. 🗓️ Date: Oct. 10 ⏰ Time: 12-1 pm ET 🔗 Register here for the meeting link: https://lnkd.in/efsvNDA9 #AmericanPharmacistsMonth #FDAOncology #PharmacyLeaders #CancerInnovation
Join the FDA Oncology Center of Excellence on Oct. 10 for American Pharmacists Month @ FDA Oncology with The Faces of FDA Pharmacy Virtual Webinar, 12-1 pm ET. Featuring FDA pharmacists and their various roles advancing oncology drug development for patients with cancer. Register to receive the meeting link ⤵ https://lnkd.in/efsvNDA9
-
🚀 The countdown is on! Just one week until The MedTech Conference in Toronto! 🌐✨ Don’t miss the opportunity to connect with Johnson & Johnson MedTech from October 15-17 and explore groundbreaking innovations shaping the future of healthcare. Booth #508 will showcase what’s next for medtech—be sure to check it out! 🔗 Register here: https://bit.ly/3ZZCR6r #MedTech2024 #HealthcareInnovation #J&JMedTech #TheMedTechConference #FutureOfHealth
The MedTech Conference is just one week away! Join us in Toronto from October 15-17 to connect with Johnson & Johnson MedTech and explore how we’re driving innovation and shaping the future of health through collaboration. Don’t miss this opportunity to engage with industry leaders and discover what’s next for medtech – find us at booth #508! Register here: https://bit.ly/3ZZCR6r #JNJMedTech #MedTechCon
-
Who benefits from precision regenerative medicine? While it promises groundbreaking advances in personalized therapies, the question of who receives those benefits is critical. Historically, clinical trials have underrepresented people of color, leading to potential gaps in treatment effectiveness for these communities. Without diverse participation, precision medicine risks perpetuating health disparities. This is why conversations like the one happening tomorrow, moderated by #BLOC leader Willie T. Reaves Jr., are so crucial. It’s time we address these inequities and ensure everyone has access to life-changing therapies. Don't miss this important discussion on equitable access to precision regenerative medicine. Link to register: https://lnkd.in/g3ND_T3p Link to article: https://lnkd.in/gpvM2Wqz
Precision regenerative medicine promises to revolutionize healthcare by offering personalized therapies that repair and regenerate damaged tissues. But precision for whom? Historically, research and clinical trials have significantly underrepresented people of color. This underrepresentation creates data gaps, leading to treatments that may be less effective—or even harmful—for these communities. Without diverse participants, clinical trials fail to account for genetic, environmental, and cultural differences that impact treatment outcomes. Without acting now, we risk perpetuating health disparities and leaving marginalized populations without access to effective therapies. That's why forums like these are critically essential and we are proud that our very own #BLOC leader, Willie T. Reaves Jr. is moderating this panel discussion tomorrow on Ensuring Equitable Access to to Precision Regenerative Medicine. This discussion will explore how we can broaden access to precision regenerative medicine by addressing key challenges at the intersection of technology, regulation, and healthcare. As personalized medicine becomes a cornerstone of modern healthcare, ensuring fair access to these groundbreaking therapies is crucial to building a future where advanced treatments reach everyone—not just a select few. This panel will be held on Wednesday, October 9, 2024 at 3:15 PM - 4:00 PM ET. Registration options linked in the comments. #BLOCLeadersinAction
-
🌟 Empowering Patients, Enhancing Research Engagement 🌟 Living with a chronic condition doesn’t mean living without hope. At WeHealth, we empower patients to drive outreach and connect them with your health initiatives, creating a bridge between patient experiences and impactful research. 💪 Empower patients to take charge. 🔗 Share your health initiatives with those who need them most. 📈 Enhance your research engagement effectively. Discover how WeHealth can help you transform your patient engagement strategy to accelerate your recruitment and make a real difference. #ChronicConditionSupport #PatientEmpowerment #HealthcareInnovation #WeHealth #ResearchEngagement
-
Don't miss Flora Koo, a Merck employee, sharing her expertise at the Black Women In Clinical Research Conference! Learn about success in clinical research. #ClinicalTrials #BWICR #Conference
We are thrilled to share that Flora Koo will be a speaker at the Black Women In Clinical Research Conference. Join us to discover the essential traits needed to thrive as a Merck employee and gain insights into the additional skills crucial for success. #ClinicalResearch #WomenLeadership #ClinicalTrials #BWICR #Atlanta #Conference
-
Reposting to highlight the incredible advancements in nuclear medicine! Theranostics offers a personalized and precise approach to treatment, targeting disease while sparing healthy cells. Learn more about these innovations here: https://lnkd.in/ec9jE-tY
Theranostics is a powerful tool in nuclear medicine, where a pair of drugs is used to both visualize and treat a disease. Not only is theranostics precise in its technique – killing only disease cells while minimizing damage to healthy ones – it’s also precise when it comes to the patient. Nuclear medicine offers the unique ability for medicine to be personalized, meaning that treatment is adapted to both the disease and the patient. But just because treatments vary doesn’t mean that protocols and safety standards should. SNMMI is a leader in ensuring that standards are created and adopted to provide the best and safest care possible for patients. Read more about our advancements in the field of theranostics. Full press release here: https://lnkd.in/ec9jE-tY
-
Excited to share how Vertex Pharmaceuticals is making strides in cystic fibrosis research! Their commitment to advancing CF research through grants like the Vertex CF Research Innovation Awards is truly inspiring. Huge credit to @VertexPharma for supporting groundbreaking work like Dr. Paul Brinkman's home-monitoring tool. Learn more about their impactful programs: https://lnkd.in/e5gjfvKH #CysticFibrosis #ResearchInnovation #VertexPharma
Advancing research in cystic fibrosis (CF) is one of the ways we strive to make a transformative impact — in our own labs and through independent research grants. Since 2014, we have supported nearly 60 projects with two programs: Vertex CF Research Innovation Awards and Vertex Innovation Awards. These programs are competitive grants created to inspire and support both up-and-coming and established CF researchers who strive to further the understanding of the disease. Dr. Paul Brinkman, a researcher at Amsterdam UMC, shared that “The Vertex Innovation Award is a marvelous support” in their goal of developing a home-monitoring tool. Learn more about our programs: https://lnkd.in/e5gjfvKH
-
Privado is providing hope for those diagnosed with prostate cancer through innovative theranostics solutions. Learn how this approach can make a difference for you or your loved one. For more information, visit privadohealth.com. #ProstateCancer #Theranostics #PrivadoHealth #CancerCare
If you or a loved one has been diagnosed with Prostate cancer, you may Theranostics may be the answer. For more information visit us at privadohealth.com
-
WeHealth reposted this
#MDScongress: Thank you to MDS International Secretariat for a wonderful, interesting and engaging conference in Philadelphia, PA. If you are interested in more #PD #Parkinson educational videos — check out https://lnkd.in/ejgVQig2 WeHealth. For other topics: https://lnkd.in/eE23wFpp If there are other conferences or topics that you want to see #RealTimeNeurology coverage of, please comment below.
RTN: Parkinson Pulse Daniel Kantor, MD - Gateway Institute for Brain Research - powered by WeHealth
https://www.youtube.com/